Home » Archive

Drug Development

Biotechnology, Drug Development, Featured, Medical Device, SDBN Blog »

INNOVATION: Finding the way from ordinary to extraordinary

Posted by Jessica Yingling June 12th, 2012 .
No Comments

The biggest question in entrepreneurship is how does one take an idea and make it reality, make it something that’s tangible and positively affects an individual and society as a whole. This was the theme at March’s SDBN networking event with Organovo, sponsored by Invetech.
Invetech helps companies translate innovations into breakthrough products.  They work with diagnostics, life sciences, medical devices, industrial, consumer and clean-tech industries.  Based in Australia, Invetech opened an office in San Diego in 2008 and has worked with a number of local companies including Organovo.
From idea to …

More...

Diagnostics, Drug Development, Drug Discovery, Featured, SDBN Blog »

San Diego’s Biotechnology Companies: Who’s Taking Off?

Posted by Lara March 8th, 2012 .
No Comments

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  But we also found a net gain in companies, with 68 added. We’ve begun to add some of the ‘provenances’ of new companies, as well as what’s happened to those that are no longer listed, and welcome your comments and additions as well, please leave them as a comment below. Note that some companies …

More...

Drug Development, Drug Discovery, Headline, SDBN Blog, SDBN Events »

SDBN March 26th 2012 Event with Organovo

Posted by Mary Canady March 6th, 2012 .
No Comments

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been included in the MIT Technology Review’s 2012 TR50 list of the world’s most innovative companies. The excitement around Organovo has grown since they recently announced funding and their stock is now publicly traded. You’ll get the chance to hear from CEO Keith Murphy at our March 26th event, he’ll give a presentation titled ‘3D Bioprinting …

More...

Diagnostics, Drug Development, Featured, SDBN Blog »

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

Posted by Lara August 26th, 2011 .
No Comments

The Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through their physicians with their own genetic information.   For those interested in self-monitoring, tracking and the impact of personal genetics, a genetic report could teach you how your genetic data can act as a guide in defining a personally-optimized lifestyle.
Pathway Genomics is a genetic and diagnostic health services company based in San Diego. Genotyping and sequencing …

More...

Drug Development, Featured, SDBN Blog »

2011 Poll Results: Drug Development, Networking Top Interests

Posted by Mary Canady February 4th, 2011 .
No Comments

Thanks to everyone who took our 2011 poll, the results are IN! See the slideshare presentation below which summarizes the results. Check out the word cloud based on the essay answers, with largest words representing those used the most frequently by respondents, helping you to understand the results as a whole visually. We had a fairly small sample size (37), and still welcome input, leave your response here or on the LinkedIn post.
2011 poll
View more presentations from Mary Canady.

We use the results to plan the 2011 schedule. Here is a …

More...

Drug Development, Headline, SDBN Blog, SDBN Events »

SDBN February 15th Event Featuring Althea Technologies

Posted by Mary Canady January 28th, 2011 .
No Comments

2011 is a new year for San Diego Biotech and we’re hoping that the good news will outweigh the bad. Let’s start off featuring a great company with a long history of success in the region, Althea Technologies. In a recent poll of members the top interest was in hearing about drug development, so you’ll really enjoy hearing about Althea’s contract development and manufacturing which helps drugs reach consumers. Maya Agarwal, Business Processes Supervisor at Althea, will present a talk about the company’s history titled “A San Diego Success Story.” …

More...

Biotechnology, Channels, Conferences, Drug Development, Featured, SDBN Blog »

Flip This Asset: San Diego’s Advanced BioHealing ‘Fixed Up’ Dermagraft for Profit and Growth #BIO2010

Posted by Mary Canady May 5th, 2010 .
No Comments

Wednesday I attended a regenerative medicine-focused breakfast at the BIO convention and learned about San Diego company Advanced BioHealing (ABH), who took a ‘fallen’ asset, Dermagraft, and not only turned it into an $85M/year product, but is also looking for new indications. Dermagraft was sold by Advanced Tissue Sciences, who had invested hundreds of millions into developing it, and even got FDA approval for the product to treat diabetic foot ulcers.
I spoke with Advanced BioHealing’s Senior VP Dean Tozer, and he describes their methodology as ‘reverse biotech,’ meaning that they …

More...

Biotechnology, Conferences, Drug Development, Featured, SDBN Blog »

How Does Biomarker Stratification Affect Drug Development Cost? It Depends. #BIO2010

Posted by Mary Canady May 5th, 2010 .
No Comments

On the San Diego Biotechnology Network LinkedIn group, we asked you what you wanted to hear about from the BIO Convention in Chicago, and you requested to hear about Biomarkers. Tuesday I attended a breakout session titled ‘Impact of Biomarkers on Drug Development Complexity and Cost,’ and it described a study done by panel members Federico Goodsaid of the FDA, Michael Palmer of Adaptive Pharmacogenomics, Mark Trusheim of MIT, Steven Averbuch of BMS, Theresa Long of the Van Andel Institute. The study modeled different scenarios utilizing biomarker information and the …

More...

Drug Development, SDBN Blog, SDBN Events, SDBN Feed »

San Diego Biotechnology Network Partner Event May 27th: Rondaxe Drug Development Symposium

Posted by Mary Canady April 22nd, 2010 .
No Comments

Drug development is an area that, according to our 2010 poll, you are interested in, and in previous meetings we’ve discussed that San Diego biotech could grow if we would better complement our drug discovery capabilities with drug development. The SDBN was approached by Rondaxe, a drug development services company, with an idea for an event which will highlight companies they work with from outside the San Diego region. The event will be held May 27th, from 9:00 a.m. to 2:15 p.m., and a light breakfast and lunch will be …

More...